|
Market Closed -
Budapest S.E.
08:49:59 18/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 12,830.00 HUF | +0.39% |
|
+2.39% | +30.06% |
| 18/09 | EU Medicines Agency Panel Issues Positive Opinion on Gedeon Richter's Arthritis Drug | MT |
| 11/08 | Gedeon Richter PLC, Q2 2026 Earnings Call, Aug 07, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 737.61Cr | |||||
| 4.68TCr | |||||
| 3.79TCr | |||||
| 1.18TCr | |||||
| 1.16TCr | |||||
| 912.48Cr |
- Stock Market
- Stocks
- RICHTER Stock
- Charts Gedeon Richter
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
